Physician-Reported Experience and Understanding of Adverse Event Attribution in Cancer Clinical Trials
Objectives: To report the results of a survey conducted among Mayo Clinic medical oncologists, hematologists, and cancer prevention specialists to better understand the current practice of determining whether an adverse event that a patient experience in a clinical trial is related to the drug under...
Main Authors: | Jennifer G. Le-Rademacher, PhD, Elizabeth M. Storrick, BA, Aminah Jatoi, MD, Sumithra J. Mandrekar, PhD |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-06-01
|
Series: | Mayo Clinic Proceedings: Innovations, Quality & Outcomes |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2542454819300074 |
Similar Items
-
Adverse Event Burden Score—A Versatile Summary Measure for Cancer Clinical Trials
by: Jennifer G. Le-Rademacher, et al.
Published: (2020-11-01) -
Remarks on the design and analyses of longitudinal studies for cancer patients with anorexia and weight loss
by: Jennifer G. Le‐Rademacher, et al.
Published: (2019-12-01) -
Succinct Cancer Clinical Trial Consent Forms in Rural Patients With Cancer: A Secondary Analysis of a Randomized, Double-Blinded study
by: Jana Wieland MD, et al.
Published: (2022-06-01) -
Evaluation of severe adverse events during rehabilitation for acute-phase patients
by: Tokio Kinoshita, RPT, PhD, et al.
Published: (2022-06-01) -
Early adverse life events are associated with altered brain network architecture in a sex- dependent manner
by: Arpana Gupta, PhD, et al.
Published: (2017-12-01)